Bristol-Myers Squibb Co
NYSE:BMY

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
NYSE:BMY
Watchlist
Price: 57.76 USD 0.31% Market Closed
Market Cap: 117.1B USD
Have any thoughts about
Bristol-Myers Squibb Co?
Write Note

Balance Sheet

Balance Sheet Decomposition
Bristol-Myers Squibb Co

Current Assets 28.1B
Cash & Short-Term Investments 8.1B
Receivables 14.9B
Other Current Assets 5.1B
Non-Current Assets 65.6B
Long-Term Investments 2.4B
PP&E 8.3B
Intangibles 48.7B
Other Non-Current Assets 6.2B
Current Liabilities 22.6B
Accounts Payable 3.5B
Accrued Liabilities 13.3B
Short-Term Debt 205m
Other Current Liabilities 5.7B
Non-Current Liabilities 53.9B
Long-Term Debt 48.7B
Other Non-Current Liabilities 5.2B

Balance Sheet
Bristol-Myers Squibb Co

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
5 571
2 385
4 237
5 421
6 911
12 346
14 546
13 979
9 123
11 464
Cash Equivalents
5 571
2 385
4 237
5 421
6 911
12 346
14 546
13 979
9 123
11 464
Short-Term Investments
1 864
1 885
2 113
1 391
1 973
3 047
1 285
2 987
130
816
Total Receivables
3 212
4 117
4 916
5 609
5 747
7 685
8 501
9 369
9 886
15 264
Accounts Receivables
2 100
2 948
3 774
4 347
4 636
6 476
7 219
7 979
8 151
9 298
Other Receivables
1 112
1 169
1 142
1 262
1 111
1 209
1 282
1 390
1 735
5 966
Inventory
1 560
1 221
1 241
1 166
1 195
4 293
2 074
2 095
2 339
2 662
Other Current Assets
2 401
807
1 197
1 267
1 334
1 983
3 786
4 832
5 795
1 564
Total Current Assets
14 608
10 415
13 704
14 854
17 160
29 354
30 192
33 262
27 273
31 770
PP&E Net
4 417
4 412
4 980
5 001
5 027
6 956
6 745
6 968
7 475
8 036
PP&E Gross
4 417
4 412
4 980
5 001
5 027
6 956
6 745
6 968
7 475
8 036
Accumulated Depreciation
4 649
4 219
4 193
3 986
3 818
3 955
3 585
4 033
4 164
4 803
Intangible Assets
1 753
1 419
1 385
1 210
1 091
63 969
53 243
42 527
35 859
27 072
Goodwill
7 027
6 881
6 875
6 863
6 538
22 488
20 547
20 502
21 149
21 169
Long-Term Investments
4 408
4 660
2 719
2 480
1 775
4 601
4 509
2 713
2 187
2 063
Other Long-Term Assets
1 536
3 961
4 044
3 143
3 395
2 576
3 245
3 342
2 877
5 049
Other Assets
7 027
6 881
6 875
6 863
6 538
22 488
20 547
20 502
21 149
21 169
Total Assets
33 749
N/A
31 748
-6%
33 707
+6%
33 551
0%
34 986
+4%
129 944
+271%
118 481
-9%
109 314
-8%
96 820
-11%
95 159
-2%
Liabilities
Accounts Payable
2 487
1 565
1 664
2 248
1 892
2 445
2 713
2 949
3 040
3 259
Accrued Liabilities
3 310
4 073
4 587
5 313
5 687
8 100
9 582
10 104
10 374
11 204
Short-Term Debt
0
0
243
987
454
583
340
184
367
246
Current Portion of Long-Term Debt
590
139
749
0
1 249
2 763
2 000
4 764
3 897
2 873
Other Current Liabilities
2 074
2 240
1 598
1 015
1 372
4 413
4 445
3 867
4 212
4 680
Total Current Liabilities
8 461
8 017
8 841
9 563
10 654
18 304
19 080
21 868
21 890
22 262
Long-Term Debt
7 242
6 550
5 716
6 975
5 646
43 387
48 336
39 605
35 056
36 653
Deferred Income Tax
0
0
0
0
0
6 454
5 407
4 501
2 166
338
Minority Interest
131
158
170
106
96
100
60
60
57
55
Other Liabilities
3 063
2 757
2 803
5 166
4 559
10 101
7 776
7 334
6 590
6 421
Total Liabilities
18 897
N/A
17 482
-7%
17 530
+0%
21 810
+24%
20 955
-4%
78 346
+274%
80 659
+3%
73 368
-9%
65 759
-10%
65 729
0%
Equity
Common Stock
221
221
221
221
221
292
292
292
292
292
Retained Earnings
32 541
31 613
33 513
31 160
34 065
34 474
21 281
23 820
25 503
28 766
Additional Paid In Capital
1 507
1 459
1 725
1 898
2 081
43 709
44 325
44 361
45 165
45 684
Unrealized Security Profit/Loss
31
23
7
32
30
6
11
2
0
2
Treasury Stock
16 992
16 559
16 779
19 249
19 574
25 357
26 237
31 259
38 618
43 766
Other Equity
2 456
2 445
2 496
2 321
2 732
1 526
1 850
1 270
1 281
1 548
Total Equity
14 852
N/A
14 266
-4%
16 177
+13%
11 741
-27%
14 031
+20%
51 598
+268%
37 822
-27%
35 946
-5%
31 061
-14%
29 430
-5%
Total Liabilities & Equity
33 749
N/A
31 748
-6%
33 707
+6%
33 551
0%
34 986
+4%
129 944
+271%
118 481
-9%
109 314
-8%
96 820
-11%
95 159
-2%
Shares Outstanding
Common Shares Outstanding
1 653
1 661
1 664
1 625
1 624
2 228
2 221
2 153
2 075
2 021
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Discover More